Skip to content
10-Q

Quarterly Report

CEN BIOTECH, INC.

0001437749-22-013244

← back to feed
Filed
May 20, 2022 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · May 17, 2022 61.8M sh
Shares Diluted Q1 2022 · Mar 31, 2022 42.42M sh
Shares Diluted Q1 2022 · Mar 31, 2021 27.58M sh
Shares Diluted Q1 2022 · Dec 31, 2020 42.42M sh
Operating Cash Flow Q1 2022 · Mar 31, 2022 −$58.02K
Operating Cash Flow Q1 2022 · Mar 31, 2021 −$61.13K
Short Term Debt Q1 2022 · Mar 31, 2022 $1.69M
Short Term Debt Q1 2022 · Dec 31, 2021 $1.69M
Cash And Equivalents Q1 2022 · Mar 31, 2022 $135.18K
Cash And Equivalents Q1 2022 · Dec 31, 2021 $193.2K
Stockholders Equity Q1 2022 · Mar 31, 2022 −$1.92M
Stockholders Equity Q1 2022 · Dec 31, 2021 −$1.66M
Stockholders Equity Q1 2022 · Mar 31, 2021 −$10.46M
Stockholders Equity Q1 2022 · Dec 31, 2020 −$9.99M
Current Liabilities Q1 2022 · Mar 31, 2022 $10.01M
Current Liabilities Q1 2022 · Dec 31, 2021 $9.86M
Total Liabilities Q1 2022 · Mar 31, 2022 $10.24M
Total Liabilities Q1 2022 · Dec 31, 2021 $10.1M
Current Assets Q1 2022 · Mar 31, 2022 $383.86K
Current Assets Q1 2022 · Dec 31, 2021 $472.22K
Total Assets Q1 2022 · Mar 31, 2022 $8.32M
Total Assets Q1 2022 · Dec 31, 2021 $8.44M
Eps Diluted Q1 2022 · Mar 31, 2022 $0.00
Eps Diluted Q1 2022 · Mar 31, 2021 −$0.02
Eps Diluted Q1 2022 · Dec 31, 2020 $0.45
Eps Basic Q1 2022 · Mar 31, 2022 $0.00
Eps Basic Q1 2022 · Mar 31, 2021 −$0.02
Eps Basic Q1 2022 · Dec 31, 2020 $0.45
Sga Expense Q1 2022 · Mar 31, 2022 $433.13K
Sga Expense Q1 2022 · Mar 31, 2021 $237.89K
Net Income Q1 2022 · Mar 31, 2022 −$258.87K
Net Income Q1 2022 · Mar 31, 2021 −$623.04K
Operating Income Q1 2022 · Mar 31, 2022 −$139.88K
Operating Income Q1 2022 · Mar 31, 2021 −$344.84K
Revenue Q1 2022 · Mar 31, 2022 $340.26K
Revenue Q1 2022 · Mar 31, 2021 $0